Immunoglobulin diversity gene usage predicts unfavorable outcome in a subset of chronic lymphocytic leukemia patients
J. Clin. Invest. Renee C. Tschumper, et al. 118:306 doi:10.1172/JCI32625 [Go to this article.]

Table 1
Molecular and clinical features of the patient cohort^A